Background Image
Previous Page  147 / 156 Next Page
Information
Show Menu
Previous Page 147 / 156 Next Page
Page Background

145

http://www.DGS-PraxisLeitlinien.de

Nr.

Nachweis

269

Reddy S, Hui D, El Osta B, de la Cruz M, Walker P, Palmer JL, Bruera E. The effect of oral

methadone on the QTc interval in advanced cancer patients: a prospective pilot study. J

Palliat Med 2010; 13(1): 33-38.

270

Reid CM, Martin RM, Sterne JA, Davies AN, Hanks GW. Oxycodone for cancer-related

pain: meta-analysis of randomized controlled trials. Arch Intern Med 2006; 166(8): 837-

843.

271

Ren S.-X, Zhang L, Zhou S.-W, Sun H, Zhou C.- C. The efficiency and safety analysis of

ibandronate an the initial loading dose for metastatic bone pain induced by non-small

cell lung cancer. Tumor 2008; 28 (4), 350 – 352.

272

Rentz AM, Yu R, Muller-Lissner S, Leyendecker P. Validation of the Bowel Function Index

to detect clinically meaningful changes in opioid-induced constipation. J Med Econ 2009;

12(4): 371-383.

273

Ridgway D, Sopata M, Burneckis A, Jespersen L, Andersen C. Clinical efficacy and safety

of once-daily dosing of a novel, prolonged-release oral morphine tablet compared with

twice-daily dosing of a standard controlled-release morphine tablet in patients with

cancer pain: a randomized, double-blind, exploratory crossover study. J Pain Symptom

Manage 2010; 39(4): 712-720.

274

Rimaitis K, Pavalkis D. Does epidural anaesthesia and analgesia really improves surgical

outcome after colorectal cancer surgery? Acta Chir Iugosl 2006; 53(2): 85-89.

275

Ringle J D, Body J J. A review of bone pain relief with ibandronate and other bisphospho-

nates in disorders of increased bone turnover. Clinical ans Experimental Rheumatology

2007; 25 (5), 766-774.

276

Ripamonti C, Fagnoni E, Campa T, Giardina V, Brunelli C, Pigni A, De Conno F. Decreases

in pain at rest and movement - related pain during zoledronic acid treatment in patients

with bone metastases due to breast or prostate cancer: a pilot study. Supprotive Care in

Cancer 2007; 15 (10), 1177-1184.

277

Ripamonti CI, Brunelli C. Comparison between numerical rating scale and six-level verbal

rating scale in cancer patients with pain: a preliminary report. Support Care Cancer 2009;

17(11): 1433-1434.

278

Ripamonti CI, Campa T, Fagnoni E, Brunelli C, Luzzani M, Maltoni M, De Conno F; MERITO

Study Group. Normal-release oral morphine starting dose in cancer patients with pain.

Clin J Pain 2009; 25(5): 386-390.

279

Rodriguez RF, Bravo LE, Castro F, Montoya O, Castillo JM, Castillo MP, Daza P, Restrepo

JM,Rodriguez MF. Incidence of weak opioids adverse events in the management of can-

cer pain: a double-blind comparative trial. J Palliat Med 2007; 10(1): 56-60.

280

Rodriguez RF, Castillo JM, Castillo MP, Montoya O, Daza P, Rodríguez MF, Restrepo JM,

León ME, Angel AM. Hydrocodone/acetaminophen and tramadol chlorhydrate combina-

tion tablets for the management of chronic cancer pain: a double-blind comparative trial.

Clin J Pain 2008; 24(1): 1-4.

Literaturverzeichnis